Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Merck KGaA's total inventories for the quarter that ended in Mar. 2026 was лв9,495 Mil. Merck KGaA's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was лв9,335 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Merck KGaA's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was лв-63.59.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Merck KGaA's Days Inventory for the
three
months ended in Mar. 2026 was 207.35.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Merck KGaA's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.44.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Merck KGaA's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.92.
Merck KGaA (XBUL:MRK) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Merck KGaA's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Merck KGaA's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Merck KGaA Total Inventories Related Terms
Merck KGaA Total Inventories Historical Data
* Premium members only.
The historical data trend for Merck KGaA's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
What does a Total Inventories of лв9,495 Mil mean?
Merck KGaA (XBUL:MRK) has a Total Inventories of лв9,495 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Merck KGaA and its competitors.
Is Merck KGaA's Total Inventories too high?
Merck KGaA's current Total Inventories is лв9,495 Mil. Overall, Merck KGaA has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Merck KGaA's Total Inventories compare to ZTS and UTHR?
Merck KGaA's Total Inventories of лв9,495 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Merck KGaA and its competitors. Merck KGaA's current Total Inventories is лв9,495 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck KGaA stock overvalued right now?
Merck KGaA (XBUL:MRK) has a current Total Inventories of лв9,495 Mil. The stock's GF Value™ is лв118.39, compared to a current price of лв114.65 — trading 3.2% below its estimated fair value. The current Total Inventories is лв9,495 Mil. Merck KGaA's overall GF Score™ is 84/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Merck KGaA (XBUL:MRK), the current Total Inventories is лв9,495 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Merck KGaA (XBUL:MRK) Overvalued in 2026?
Based on GuruFocus' analysis, Merck KGaA stock appears to be undervalued.
The current stock price of лв114.65 is trading 3.2% below its estimated GF Value™ of лв118.39.
Key valuation signals for XBUL:MRK:
Total Inventories: лв9,495 Mil
GF Value™: лв118.39 vs. price of лв114.65 (3.2% below fair value)
No single metric tells the full story. See the XBUL:MRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
84GF Score
Get the complete analysis for XBUL:MRK
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XBUL:MRK has been successfully added to your 
